file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
1401 | SECRETED | 3 | 7 | 68 |
1402 | SELECTION | 7 | 29 | 68 |
1403 | TECHNIQUE | 12 | 28 | 68 |
1404 | TH2 | 4 | 3 | 68 |
1405 | A-INDUCED | 5 | 7 | 67 |
1406 | ACCUMULATION | 2 | 4 | 67 |
1407 | CORRECTABLE | 1 | 10 | 67 |
1408 | INTRA-ABDOMINAL | 1 | 10 | 67 |
1409 | LEUKEMIA | 5 | 7 | 67 |
1410 | LYMPHOCYTE-TRANSFORMING | 1 | 1 | 67 |
1411 | NITRIC-OXIDE | 1 | 0 | 67 |
1412 | PEPTIDE-PULSED | 1 | 0 | 67 |
1413 | PRINCIPLES | 3 | 11 | 67 |
1414 | PROGENITOR-DERIVED | 1 | 0 | 67 |
1415 | SENSITIVE | 3 | 17 | 67 |
1416 | STREPTOLYSIN | 1 | 1 | 67 |
1417 | SURGICALLY | 1 | 10 | 67 |
1418 | TACROLIMUS-BASED | 3 | 6 | 67 |
1419 | VACCINATED | 1 | 0 | 67 |
1420 | VACCINES | 2 | 1 | 67 |
1421 | ACETATE | 2 | 2 | 66 |
1422 | ADOPTIVE | 2 | 5 | 66 |
1423 | BLOOD-GROUP | 3 | 2 | 66 |
1424 | CLINICAL-PHARMACOLOGY | 1 | 1 | 66 |
1425 | CULTURE | 7 | 7 | 66 |
1426 | HAND | 5 | 3 | 66 |
1427 | JAUNDICE | 1 | 4 | 66 |
1428 | NONIMMUNOLOGICALLY | 1 | 4 | 66 |
1429 | TRIPLE-DRUG | 2 | 8 | 66 |
1430 | UNFINISHED | 2 | 19 | 66 |
# | Word | Recs | TLCS | TGCS |
1431 | 19S-ANTIBODY | 1 | 0 | 65 |
1432 | ACTIVATED | 6 | 8 | 65 |
1433 | ACTIVATION-ASSOCIATED | 1 | 32 | 65 |
1434 | ALLOREACTIVE | 5 | 18 | 65 |
1435 | AUTOGRAFTS | 5 | 2 | 65 |
1436 | BARRIER | 5 | 12 | 65 |
1437 | CONVALESCENCE | 1 | 34 | 65 |
1438 | CYSTINOSIS | 1 | 2 | 65 |
1439 | CYTOKINES | 1 | 0 | 65 |
1440 | DATA | 6 | 2 | 65 |
1441 | NONSURGICAL | 1 | 4 | 65 |
1442 | SEMI-AUTOMATED | 1 | 1 | 65 |
1443 | SUPRALETHALLY | 1 | 44 | 65 |
1444 | TH1 | 3 | 8 | 65 |
1445 | THROMBOSIS | 3 | 6 | 65 |
1446 | TRANSIENT | 6 | 9 | 65 |
1447 | 25-YEAR | 2 | 15 | 64 |
1448 | CALCINEURIN-MEDIATED | 1 | 4 | 64 |
1449 | CARCINOMA | 3 | 0 | 64 |
1450 | COAGULATION | 3 | 13 | 64 |
1451 | DERMATOMYOSITIS | 2 | 2 | 64 |
1452 | FATE | 5 | 10 | 64 |
1453 | INSULIN-SECRETION | 2 | 20 | 64 |
1454 | LIQUID-CHROMATOGRAPHY | 5 | 5 | 64 |
1455 | MINNESOTA | 4 | 14 | 64 |
1456 | QUANTIFICATION | 5 | 8 | 64 |
1457 | SUBLIMINAL | 1 | 0 | 64 |
1458 | SYMPATHETIC | 1 | 4 | 64 |
1459 | AUGMENTED | 2 | 28 | 63 |
1460 | DEFICITS | 1 | 8 | 63 |
# | Word | Recs | TLCS | TGCS |
1461 | FKBP-52 | 1 | 10 | 63 |
1462 | GAMMA-DELTA | 1 | 5 | 63 |
1463 | HLA-MATCHED | 2 | 4 | 63 |
1464 | HYPERAMYLASEMIA | 1 | 9 | 63 |
1465 | IMMUNOCOMPROMISED | 1 | 16 | 63 |
1466 | INCLUDING | 5 | 9 | 63 |
1467 | MARROW-AUGMENTED | 3 | 42 | 63 |
1468 | MIDDLE | 1 | 8 | 63 |
1469 | MOTOR | 1 | 8 | 63 |
1470 | OCCLUSION | 1 | 8 | 63 |
1471 | POTASSIUM | 2 | 5 | 63 |
1472 | SKILLED | 1 | 8 | 63 |
1473 | SKIN-GRAFTS | 1 | 5 | 63 |
1474 | TECHNIQUES | 4 | 6 | 63 |
1475 | THEORIES | 1 | 4 | 63 |
1476 | APPRAISAL | 1 | 14 | 62 |
1477 | CLINICAL-APPLICATIONS | 4 | 3 | 62 |
1478 | DEFICIENT | 2 | 0 | 62 |
1479 | DELAYED-HYPERSENSITIVITY | 1 | 1 | 62 |
1480 | GM-CSF | 3 | 8 | 62 |
1481 | HYPERTROPHY | 3 | 0 | 62 |
1482 | MASSIVE | 4 | 1 | 62 |
1483 | NONREJECTING | 1 | 9 | 62 |
1484 | PEPTIDYL-PROLYL | 3 | 3 | 62 |
1485 | PROPHYLACTIC | 3 | 4 | 62 |
1486 | THYMIC | 5 | 16 | 62 |
1487 | VEIN | 4 | 10 | 62 |
1488 | ANEMIA | 4 | 3 | 61 |
1489 | ANTILYPHOCYTE-GLOBULIN | 1 | 10 | 61 |
1490 | BRAIN-TYPE | 1 | 0 | 61 |
# | Word | Recs | TLCS | TGCS |
1491 | HCV | 2 | 16 | 61 |
1492 | INTRATHYMIC | 11 | 20 | 61 |
1493 | MICROEMULSIFIED | 2 | 11 | 61 |
1494 | NEWLY | 4 | 5 | 61 |
1495 | OX-2 | 1 | 0 | 61 |
1496 | PERIODONTIST | 1 | 2 | 61 |
1497 | PHARMACODYNAMICS | 1 | 6 | 61 |
1498 | REANALYSIS | 1 | 4 | 61 |
1499 | RYANODINE | 1 | 0 | 61 |
1500 | THROMBOEMBOLIC | 3 | 5 | 61 |
1501 | CO-STIMULATOR | 1 | 0 | 60 |
1502 | FORBIDDEN | 1 | 19 | 60 |
1503 | LIMITED | 2 | 0 | 60 |
1504 | LIVER-GRAFT | 1 | 17 | 60 |
1505 | LOW-DOSES | 2 | 10 | 60 |
1506 | NEUROREGENERATIVE | 2 | 5 | 60 |
1507 | REFERENCES | 1 | 19 | 60 |
1508 | TGF-BETA | 1 | 1 | 60 |
1509 | CAMPATH-1H | 1 | 11 | 59 |
1510 | CYCLOPHOSPHAMIDE-INDUCED | 4 | 2 | 59 |
1511 | ENHANCED | 6 | 8 | 59 |
1512 | ERYTHROCYTE | 2 | 2 | 59 |
1513 | FAVOURABLY | 1 | 16 | 59 |
1514 | IMPACTS | 1 | 16 | 59 |
1515 | NEAR-MONOTHERAPY | 1 | 11 | 59 |
1516 | OCULAR | 5 | 1 | 59 |
1517 | PD-L1 | 2 | 7 | 59 |
1518 | PITFALLS | 3 | 5 | 59 |
1519 | REGION | 3 | 17 | 59 |
1520 | RETROSPECTIVE | 6 | 1 | 59 |
# | Word | Recs | TLCS | TGCS |
1521 | SUPPRESSES | 3 | 4 | 59 |
1522 | 11-YEAR | 2 | 0 | 58 |
1523 | ACID | 5 | 2 | 58 |
1524 | ANTI | 4 | 7 | 58 |
1525 | B7-H1-MEDIATED | 1 | 2 | 58 |
1526 | BASED | 4 | 14 | 58 |
1527 | CYTO-TOXIC | 2 | 1 | 58 |
1528 | DECEASED-DONOR | 1 | 16 | 58 |
1529 | DISCOVERY | 4 | 7 | 58 |
1530 | ERYTHEMATOUS | 1 | 2 | 58 |
1531 | FOXP3 | 2 | 1 | 58 |
1532 | GUIDELINES | 2 | 1 | 58 |
1533 | HISTOCOMPATIBLE | 1 | 5 | 58 |
1534 | MEMORY | 5 | 3 | 58 |
1535 | NESTED | 4 | 30 | 58 |
1536 | PARADIGMS | 2 | 39 | 58 |
1537 | PEDIATRICS | 1 | 11 | 58 |
1538 | REQUIREMENTS | 2 | 6 | 58 |
1539 | TEMPORARY | 2 | 7 | 58 |
1540 | ACQUIRED | 10 | 12 | 57 |
1541 | CLOSED | 1 | 0 | 57 |
1542 | DETECTING | 1 | 13 | 57 |
1543 | ENTERS | 1 | 18 | 57 |
1544 | FLUIDS | 1 | 0 | 57 |
1545 | MACROCHIMERISM | 3 | 17 | 57 |
1546 | MILESTONES | 2 | 36 | 57 |
1547 | OPSONIC | 1 | 0 | 57 |
1548 | PLASMACYTOID | 2 | 7 | 57 |
1549 | REMOVE | 1 | 0 | 57 |
1550 | RESEARCH | 9 | 6 | 57 |
# | Word | Recs | TLCS | TGCS |
1551 | RIA | 1 | 3 | 57 |
1552 | SOLUTION | 3 | 2 | 57 |
1553 | SUCTION | 1 | 0 | 57 |
1554 | TREATING | 1 | 13 | 57 |
1555 | CARE | 5 | 2 | 56 |
1556 | CORRECTION | 1 | 0 | 56 |
1557 | DOUBLE-DRUG | 1 | 7 | 56 |
1558 | FIELD | 2 | 2 | 56 |
1559 | MATTER | 1 | 1 | 56 |
1560 | PRECONDITIONING | 3 | 15 | 56 |
1561 | PREFERENTIAL | 4 | 10 | 56 |
1562 | SUCCESS | 4 | 25 | 56 |
1563 | ALTERED | 4 | 2 | 55 |
1564 | CAMBRIDGE | 1 | 2 | 55 |
1565 | DONOR-TYPE | 8 | 18 | 55 |
1566 | DYNAMIC | 5 | 9 | 55 |
1567 | ERYTHREMIA | 1 | 4 | 55 |
1568 | GREEN | 3 | 4 | 55 |
1569 | HUNDRED | 2 | 3 | 55 |
1570 | IMPROVEMENTS | 2 | 8 | 55 |
1571 | INSUFFICIENCY | 3 | 2 | 55 |
1572 | KINGS-COLLEGE-HOSPITAL | 1 | 2 | 55 |
1573 | LATE-ONSET | 1 | 8 | 55 |
1574 | LIPID | 5 | 1 | 55 |
1575 | OCCURRENCE | 5 | 10 | 55 |
1576 | PRODUCT | 2 | 7 | 55 |
1577 | SERIES | 1 | 2 | 55 |
1578 | SURFACE | 4 | 5 | 55 |
1579 | TOLERANCE-INDUCING | 3 | 8 | 55 |
1580 | 2-WAY | 1 | 36 | 54 |
# | Word | Recs | TLCS | TGCS |
1581 | 20-YEAR | 3 | 0 | 54 |
1582 | ANURIA | 1 | 28 | 54 |
1583 | COLLECTIVE | 2 | 0 | 54 |
1584 | DISORDER | 3 | 1 | 54 |
1585 | EXPRESSING | 3 | 12 | 54 |
1586 | HOSPITALS | 2 | 11 | 54 |
1587 | IMMEDIATE | 1 | 28 | 54 |
1588 | NUCLEAR-MAGNETIC-RESONANCE | 3 | 2 | 54 |
1589 | OLIGURIA | 1 | 28 | 54 |
1590 | ONE-WAY | 1 | 36 | 54 |
1591 | QUADRUPLE | 5 | 2 | 54 |
1592 | SOLID-ORGAN | 5 | 24 | 54 |
1593 | VIEWED | 1 | 36 | 54 |
1594 | ASSESSING | 1 | 1 | 53 |
1595 | BIOBSIES | 1 | 13 | 53 |
1596 | CARDIOVASCULAR | 3 | 5 | 53 |
1597 | CROSSMATCH | 1 | 1 | 53 |
1598 | DIFFERENCES | 5 | 9 | 53 |
1599 | DMBA | 1 | 1 | 53 |
1600 | ELECTRON | 1 | 13 | 53 |